Familial renal cell carcinoma from the Swedish Family-Cancer Database.

Genetic control of renal tumorigenesis by the mouse Rtm1 locus. BMC Genomics (2013) 0.76

Familial clustering of sporadic kidney cancer: insufficient evidence to recommend routine screening in unaffected kin. Eur Urol (2011) 0.75

Re: familial renal cell carcinoma from the Swedish family-cancer database. J Urol (2012) 0.75

Appearance of malignant melanoma after a non-cutaneous cancer diagnosis. Ecancermedicalscience (2013) 0.75

Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma. Can Urol Assoc J (2016) 0.75

TERT promoter mutations in familial and sporadic melanoma. Science (2013) 7.82

Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26

Urbanisation and incidence of psychosis and depression: follow-up study of 4.4 million women and men in Sweden. Br J Psychiatry (2004) 4.94

New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15

Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer (2002) 3.55

Gestational age at birth and mortality in young adulthood. JAMA (2011) 3.31

BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res (2003) 3.21

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet (2010) 2.47

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43

Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med (2002) 2.38

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol (2012) 2.32

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood (2007) 2.31

Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst (2005) 2.23

Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study. BMJ (2013) 2.16

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics (2008) 2.11

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis (2008) 2.09

IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry (2014) 2.05

Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood (2004) 2.05

Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry (2013) 2.03

Mesothelioma is a killer of urban men in Sweden. Int J Cancer (2003) 2.02

Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Arch Gen Psychiatry (2012) 2.00

Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol (2009) 1.95

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90

Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects. Scand J Public Health (2006) 1.85

SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis (2008) 1.84

Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet (2011) 1.83

Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Oncogene (2003) 1.82

Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation (2012) 1.82

Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry (2014) 1.82

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A (2013) 1.82

Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol (2004) 1.80

Do immigrants have an increased prevalence of unhealthy behaviours and risk factors for coronary heart disease? Eur J Cardiovasc Prev Rehabil (2005) 1.79

Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis (2003) 1.78

Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74

Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73

Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum (2009) 1.73

Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73

SNP microarray analysis for genome-wide detection of crossover regions. Hum Genet (2005) 1.68

BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J Invest Dermatol (2005) 1.66

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis. PLoS One (2007) 1.65

Neighborhood violent crime and unemployment increase the risk of coronary heart disease: a multilevel study in an urban setting. Soc Sci Med (2005) 1.65

Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood (2009) 1.64

Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control (2007) 1.61

Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer (2006) 1.61

Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60

Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays. Am J Hum Genet (2006) 1.60

Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer (2004) 1.56

Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54

The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis (2002) 1.53

Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost (2013) 1.50

Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum (2008) 1.50

Preterm birth and risk of medically treated hypothyroidism in young adulthood. Clin Endocrinol (Oxf) (2011) 1.48

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis (2005) 1.48

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol (2007) 1.47

Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45

Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum (2009) 1.45

Gestational age at birth and risk of testicular cancer. Int J Cancer (2011) 1.45

Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 1.45

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood (2013) 1.45

Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat (2010) 1.45

A bias in genotyping the ERBB2 (HER2) Ile655Val variant. Carcinogenesis (2005) 1.44

Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer (2008) 1.44

The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer (2010) 1.42

Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Breast Cancer Res Treat (2009) 1.42

Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41

Association of first ocular melanoma with subsequent cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer (2003) 1.41

Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry (2013) 1.40

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum Mol Genet (2008) 1.40

Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure. Scand Cardiovasc J (2014) 1.40

Ethnicity, acculturation, and self reported health. A population based study among immigrants from Poland, Turkey, and Iran in Sweden. J Epidemiol Community Health (2004) 1.39

Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev (2012) 1.39

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer (2006) 1.38

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk. Breast Cancer Res Treat (2010) 1.38

Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst (2008) 1.36

MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis (2007) 1.35

Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci U S A (2008) 1.34

Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst (2007) 1.34

Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood (2005) 1.33

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer (2007) 1.32

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat (2009) 1.30

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer (2010) 1.30

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28

Physical activity, exercise and self-rated health: a population-based study from Sweden. BMC Public Health (2008) 1.26

Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol (2009) 1.25

The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat (2007) 1.24

Aurora kinases A and B and familial breast cancer risk. Cancer Lett (2006) 1.24

Within-family environmental transmission of drug abuse: a Swedish national study. JAMA Psychiatry (2013) 1.20

Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis (2007) 1.20

Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis (2006) 1.19

Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol (2010) 1.18

Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull (2012) 1.18

Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev (2008) 1.18